Bloomin' Brands
BLMN:US US0942351083
Key Information
HQ:
United States
Market Cap:
$1.87bn
Primary Market:
North America
Antibiotics Stewardship Engagement
Analysis Overview
Scope of Policy Policy Implementation Investor Engagement
Analysis Breakdown
Scope of Policy
2/16
Does the company have a policy on antibiotics stewardship?
The company a public policy on antibiotics. In their response to FAIRR, the company stated that this is being reviewed and the company will provide a public statement once work on the policy has been completed. There is no date for the publication of this policy.
2/4
Does it cover animal-derived protein sources across all relevant species?
No policy.
0/4
Does it cover animal-derived protein sources across all operations?
No policy.
0/4
How strong is the company's commitment?
No policy.
0/4
Policy Implementation
0/18
Does the policy commit to specific targets or timelines for all species?
No information provided and/ or available.
0/5
Does the company disclose quantity of antibiotics used?
No information provided and/ or available.
0/7
Does the company commit to and/ or carries out third-party auditing and monitoring?
No information provided and/ or available.
0/6
Investor Engagement
1/4
Did the company respond to investor letter?
Bloomin' Brands responded to the investor letter with a brief statement that they are currently reviewing their antibiotics use policy. No further information was provided, and the company has not met with FAIRR. Their response is available here.
1/4
Workstream Information
2019 Score:
3/38
Last Updated:
20 May 2019
2019 Resources
Phase 3 | Progress Report Antibiotics Stewardship Engagement